3
TITLE: Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced
AUTHORS: Ferreira, JP ; Anker, SD; Butler, J; Filippatos, G; Iwata, T; Salsali, A; Zeller, C; Pocock, SJ; Zannad, F; Packer, M;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 40
4
TITLE: Reconsidering the ejection fraction centric view of pharmacologic treatment for heart failure
AUTHORS: Ferreira, JP ; Packer, M; Butler, J; Zannad, F;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE
INDEXED IN: WOS CrossRef: 12
5
TITLE: Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction  Full Text
AUTHORS: Ferreira, Joao Pedro ; Butler, Javed; Zannad, Faiez; Filippatos, Gerasimos; Schueler, Elke; Steubl, Dominik; Zeller, Cordula; Januzzi, James L.; Pocock, Stuart; Packer, Milton; Anker, Stefan D.;
PUBLISHED: 2022, SOURCE: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOLUME: 79, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 40
6
TITLE: Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
AUTHORS: Butler, Javed; Filippatos, Gerasimos; Siddiqi, Tariq Jamal; Brueckmann, Martina; Bohm, Michael; Chopra, Vijay K.; Ferreira, Joao Pedro ; Januzzi, James L.; Kaul, Sanjay; Pina, Ileana L.; Ponikowski, Piotr; Shah, Sanjiv J.; Senni, Michele; Vedin, Ola; Verma, Subodh; Peil, Barbara; Pocock, Stuart J.; Zannad, Faiez; Packer, Milton; Anker, Stefan D.;
PUBLISHED: 2022, SOURCE: CIRCULATION, VOLUME: 145, ISSUE: 3
INDEXED IN: WOS CrossRef: 122
7
TITLE: Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions
AUTHORS: Anker, Stefan D.; Siddiqi, Tariq Jamal; Filippatos, Gerasimos; Zannad, Faiez; Ferreira, Joao Pedro ; Pocock, Stuart J.; Brueckmann, Martina; Zeller, Cordula; Packer, Milton; Butler, Javed;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 13
8
TITLE: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
AUTHORS: Ferreira, Joao Pedro ; Zannad, Faiez; Butler, Javed; Filipattos, Gerasimos; Ritter, Ivana; Schuler, Elke; Kraus, Bettina J.; Pocock, Stuart J.; Anker, Stefan D.; Packer, Milton;
PUBLISHED: 2022, SOURCE: EUROPEAN HEART JOURNAL, VOLUME: 43, ISSUE: 31
INDEXED IN: Scopus WOS CrossRef: 42
9
TITLE: Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced
AUTHORS: Zannad, Faiez; Ferreira, Joao Pedro ; Gregson, John; Kraus, Bettina Johanna; Mattheus, Michaela; Hauske, Sibylle Jenny; Butler, Javed; Filippatos, Gerasimos; Wanner, Christoph; Anker, Stefan D.; Pocock, Stuart J.; Packer, Milton;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 23
10
TITLE: Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
AUTHORS: Pocock, Stuart J.; Ferreira, Joao Pedro ; Packer, Milton; Zannad, Faiez; Filippatos, Gerasimos; Kondo, Toru; McMurray, John J., V; Solomon, Scott D.; Januzzi, James L.; Iwata, Tomoko; Salsali, Afshin; Butler, Javed; Anker, Stefan D.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 24, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 28
Page 1 of 3. Total results: 21.